ANN ARBOR, Mich., June 10 /PRNewswire/ -- The 2005 Michigan Growth Capital Symposium (MGCS) announced today the second set of presenting companies in the life sciences track. These companies will present on the second day, June 16, at the 24th annual symposium held at the University of Michigan Ross School of Business.
The 2005 MGCS conference will showcase 32 companies carefully screened by members of the Midwest venture capital community in information technology, life sciences and alternative energy. These companies represent the highest quality deals in the Midwest.
Presenting companies in the field of life sciences include:
Accuri Instruments, Inc. is a development stage company with a single focus: development, manufacturing and sales of innovative flow cytometers. Accuri’s vision is to improve and expand the use of flow cytometry in life sciences research and beyond.
Avidimer Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted therapeutics to treat cancer and other diseases. Its first product candidate, ATI-001, is expected to enter human clinical trials in 2006.
Genetics Squared’s evolutionary drug development(TM) technology and process (SKGP) delivers on the promise of personalized medicine by taking drugs in clinical development that show distinct, yet infrequent, efficacy and developing clinical rules and diagnostics that can identify and characterize these subpopulations of responders.
Incept BioSystems has successfully developed a powerful microfluidic cell culture diagnostic platform that closely mimics the flow rate and scale environments found in human vascular systems. The platform has the potential to revolutionize how cell researchers and clinicians culture and analyze cells and tissue.
Kereos is developing targeted therapeutics and imaging agents to better treat cancer. While the company’s targeted imaging agents provide more predictive diagnosis and the targeted therapeutics provide effective, precisely-targeted chemotherapy, these products can be combined to offer even more effective disease management.
Midway Pharmaceuticals has been founded around the discovery that an orally available, non-systemically absorbed Polymer BioShield(TM) inhibits the pathogenic behavior of bacteria in the GI tract without the use of antibiotics.
Natural Therapeutics LLC was formed to exclusively market several patented bio-active compounds developed by the Michigan State University Center for Food Safety and Toxicology. Natural Therapeutics has developed and patented numerous food safe novel compounds found in botanicals, which when isolated and purified can be sold as food supplements and pharmaceuticals for specific disease prevention and treatment.
Oncologic, Inc. is a Bay-area biotechnology company founded in January 2000 with headquarters in Richmond, CA. Oncologic is developing a revolutionary intravenous nanobiotechnology therapy for solid cancers (breast, prostate, colon, lung, etc.).
MGCS is June 15 and 16 at the University of Michigan Ross School of Business, Ann Arbor, Michigan. The cost is $495 for the first registrant from each firm and $395 for each additional registrant from that firm until Monday, June 13. All attendees after June 13 can register onsite for $600. Further agenda details and online registration for the event are available at http://www.MichiganGCS.com .
About the Michigan Growth Capital Symposium
During the past 24 years, the Michigan Growth Capital Symposium has earned a reputation as the conference ‘where deals get done’ between aspiring entrepreneurs and noted venture capitalists. The conference, hosted by The University of Michigan Ross School of Business’s Center for Venture Capital and Private Equity, is one of a series of nationally recognized venture capital, private equity finance seminars and investor events presented by the Center.
Dr. David J. Brophy, director of the Center, teaches and conducts research on private equity markets. For more information and to register, visit the Web site at http://www.MichiganGCS.com .
Michigan Growth Capital Symposium
CONTACT: Jessica Annaloro of Eiler Communications, +1-734-761-3399,Jessica@EilerPR.com , for Michigan Growth Capital Symposium
Web site: http://www.MichiganGCS.com/
